Single dose of psychedelic nasal spray reduced treatment-resistant depression symptoms for eight weeks
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
A JAMA trial reported that one dose of synthetic mebufotenin nasal spray eased treatment-resistant depression within a day, with benefits lasting up to eight weeks. Patients on the active dose improved more on a standard depression scale than those on a low comparator dose; most were assessed ready to leave the clinic within two hours after a brief psychoactive episode, unlike longer psilocybin sessions that need four to twelve hours in clinic.
Continue in the app — vote & join in ➔Source: PsyPost · via ahirlevel.hu